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Abstract
Background: The relationships among serum bilirubin concentration, kidney function and proteinuria have yet to
be fully elucidated, nor have these relationships been investigated in Korean adults.
Method: We retrospectively reviewed the medical records of Korean adults who were evaluated at Kosin University
Gospel Hospital (Busan, Republic of Korea) during a five-year period from January 2005 to December 2009. We
evaluated the relationships among serum bilirubin concentration, estimated glomerular filtration rate (eGFR) and
24-hour urinary protein excretion in a sample of 1363 Korean adults aged 18 years or older.
Results: The values of eGFR <60 mL/min/1.73 m
2 and 24-hour urine albumin ≥150 mg/day were observed in 26.1% (n
= 356) and 40.5% (n = 553) of subjects, respectively. Fasting glucose levels ≥126 mg/dL were observed in 44.9% (n =
612) of the total sample. After adjustment for potential confounding factors including demographic characteristics,
comorbidities and other laboratory measures, total serum bilirubin was positively associated with eGFR and negatively
associated with proteinuria both in the whole cohort and in a subgroup of diabetic individuals.
Conclusions: To our knowledge, this is the first hospital-based study specifically aimed at examining the
relationships among serum total bilirubin concentration, 24-hour urine protein and kidney function in Korean
adults. We demonstrated that serum total bilirubin concentration was negatively correlated with 24-hour urine
protein and positively correlated with eGFR in Korean non-diabetic and diabetic adults.
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Background
T h ep r e v a l e n c eo fc h r o n i ck i d n e yd i s e a s ei si n c r e a s i n g
worldwide [1,2]. Reduced eGFR and abnormal protei-
nuria have been associated with increased risk of end
stage renal disease (ESRD), cardiovascular disease and
other comorbidities [3-6]. Because renal disease often
progresses to ESRD, the identification of risk factors for
kidney disease progression is essential.
Increased concentrations of serum bilirubin have long
been used as a marker of liver dysfunction. In addition,
serum bilirubin is not merely an end product of heme
degradation but is also a potent antioxidant that acts via
inhibitions of NADPH oxidase, a key source of oxidants
in phagocytic and non-phagocytic cells, and of protein
kinase C activity [7-9].
Information on the associations of serum bilirubin
concentration with renal function and proteinuria is
limited and controversial. Fukui et al. found that total
serum bilirubin was positively associated with eGFR and
negatively associated with albuminuria in a hospital-
based sample of 633 Japanese type 2 diabetic patients
[10], indicating that bilirubin has a potential renoprotec-
tive effect. In contrast, Targher et al. found that a higher
total serum bilirubin was significantly associated with
lower eGFR in both non-diabetic and diabetic indivi-
duals in a group of 2678 unselected outpatients 35 years
of age or older [11].
To date, the associations of serum bilirubin concentra-
tion with kidney function and proteinuria have not been
established in a Korean adult population. Therefore, we
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centration, eGFR and the degree of 24-hour urinary pro-
tein excretion in patients at Kosin University Gospel
Hospital (Busan, Republic of Korea) during a five-year
period from January 2005 to December 2009.
Methods
Patients
We retrospectively reviewed the medical records of Kor-
ean adults patients who had visited Kosin University
Gospel Hospital (Busan, Republic of Korea) from Janu-
ary 2005 to December 2009 and evaluated the relation-
ships among serum bilirubin concentration, eGFR and
24-hour urinary protein excretion in a sample of 1363
Korean adults aged 18 years or older (669 men, 694
women, aged 54.6 ± 15.1 years, range 18-93 years). The
study was reviewed and approved by the Ethics Com-
mittee of Kosin University Gospel Hospital.
Clinical and biochemical assessments
Type 2 diabetes was diagnosed according to the Report
of the Expert Committee on the Diagnosis and Classifi-
cation of Diabetes Mellitus [12]. Nephropathy was
graded as follows: normoproteinuria, urinary protein
excretion less than 150 mg/day and macroproteinuria,
greater than 150 mg/day.
As a surrogate for measuring renal function in the
subjects, we estimated the GFR using a simplified form
of the Modification of Renal Disease (MDRD) equation
[13]. The equation is as follows:
GFR = 186 × [Scr]−1.154 × [Age]−0.203 × [0.742 if patient is female]
The exclusion criteria were as follows:
1) patients with malignant disease, liver cirrhosis, or
hematologic disease;
2) patients with advanced renal dysfunction (serum
creatinine level higher than 2.0 mg/dL);
3) patients whose serum bilirubin concentrations were
greater than 1.2 mg/dL due to the high possibility of
Gilbert syndrome.
4) patients with chronic hepatitis B or C
Total serum bilirubin concentrations (normal ranges:
0.2-1.0 mg/dL) were measured using an enzymatic
method with bilirubin oxidase on an automatic analyzer
(Hitachi 7600). Serum total cholesterol, high-density lipo-
protein cholesterol, and triglyceride concentrations were
assessed using standard enzymatic methods. Twenty-
four-hour urine samples were collected from patients
who demonstrated proteinuria in a dipstick urine test.
Statistical analysis
The results are presented as the mean ± SD. We used Stu-
dent’s t test to compare the means and Pearson’s
correlation coefficient to evaluate the relationships
between parameters. The association between serum total
bilirubin and eGFR and the association between serum
total bilirubin and 24 hour urine protein were investigated
using linear (adjusted) regression models in the whole
group and in subgroups of patients stratified by diabetes
status. The covariates included in adjusted regression
models were age, sex, diabetes, hypertension, total choles-
terol, LDL-cholesterol, HDL-cholesterol and triglyceride.
The results were considered significant when the P value
was less than 0.05. All statistical analyses were performed
using the Statistical Package for the Social Sciences (SPSS)
version 12.0 (SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the 1363 subjects enrolled in this
study are shown in Table 1.
Table 1 Clinical characteristics of subjects
Variable Mean ± s.d.
n 1,363
Age (years) 55.6 ± 14.1
Sex,%
Males 49.1
Females 50.9
Diabetes,% 44.9
Hypertension,% 14.0
Measurements
Urine protein, mg/day 806 ± 2,150
WBC, mm
3 7,619 ± 3,083
Hb, g/dL 12.2 ± 1.9
Platelet, mm
3 260,398 ± 98,162
Protein, g/dL 6.7 ± 2.7
Albumin, g/dL 3.8 ± 0.6
Total cholesterol, mg/dL 204 ± 77
LDL Cholesterol, mg/dL 115 ± 43
HDL cholesterol, mg/dL 44 ± 15
Triglycerides, mg/dL 158 ± 209
AST, IU/L 28 ± 22
ALT, IU/L 27 ± 24
Fasting blood glucose, mg/dL 144 ± 73
BUN, mg/dL 18.6 ± 10.4
Creatinine, mg/dL 1.16 ± 0.64
eGFR, mL/min/1.73 m
2 75 ± 31
Uric acid, IU/L 5.4 ± 2.0
Sodium, mEq/L 140.6 ± 4.8
Potassium, mEq/L 4.2 ± 0.6
Calcium, mg/dL 9.1 ± 0.7
Phosphorus, mg/dL 4.0 ± 3.1
Chloride, mEq/L 102 ± 11
total CO2, mEq/L 26.4 ± 4.9
Total Bilirubin, mg/dL 0.75 ± 0.21
Direct Bilirubin, mg/dL 0.30 ± 0.09
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Page 2 of 7Among the 1363 adult subjects, the mean age and
total bilirubin were 55.6 (± 14.1) years and 0.75 (± 0.21)
mg/dL, respectively. An eGFR <60 mL/min/1.73 m
2 and
a 24-hour urine protein ≥1 5 0m g / d a yw e r ep r e s e n ti n
26.1% (n = 356) and 40.5% (n = 553) of the subjects,
respectively. Diabetes and hypertension were present in
44.9% (n = 612) and 14.0% (n = 191) of patients.
The clinical and biochemical characteristics of subjects
stratified according to eGFR category are summarized in
Table 2. Compared with patients with normal or near-
normal eGFR, persons with lower eGFR were older,
more likely to be male, and had greater prevalence for
high serum total bilirubin concentration. A positive cor-
relation was found between serum total bilirubin con-
centration and eGFR in all subjects and in diabetic
patients (r = 0.128, p = 0.0001; r = 0.202, p = 0.0001)
(Figure 1, 2). An inverse correlation was found between
total serum bilirubin concentration and 24-hour urine
albumin in all subjects and in subjects with diabetes (r =
-0.228, p = 0.0001; r = -0.227, p = 0.0001) (Figure 3, 4).
When participants were stratified into categories based
on proteinuria (Table 3), persons with higher protei-
nuria were hypoalbuminemic, more likely to be male,
hypercholesterolemic (although level of LDL was
Table 2 Age-gender standardized baseline demographics and laboratory results accordings to eGFR in the entire
cohort (n = 1,363)
eGFR Characteristics ≥90 mL/min/
1.73 m
2, n = 564
60-89 mL/min/1.73 m
2,
n = 443
30-59 mL/min/1.73 m
2,
n = 265
15-29 mL/min/1.73 m
2,
n=9 1
p-
value
Age, years 50.1 ± 13.8 57.3 ± 13.8 59.3 ± 13.7 59.4 ± 14.6 0.0001
T
1) ab , c c c
Sex,%
Males 46 48.3 54.3 56
Females 54 51.7 45.7 44
Diabetes,% 52.8 45.1 32.8 29.4
Hypertension,% 10.1 12.1 23.3 21.2
Measurements
Urine protein, mg/day 572 ± 1,871 744 ± 2,366 1,231 ± 2,236 2,050 ± 3047 0.0001
T
1) aa , b b c
WBC, mm
3 7,420 ± 3,116 7,534 ± 3,112 7,940 ± 3,003 7,909 ± 2,967 0.252
Hb, g/dL 12.5 ± 1.7 12.5 ± 1.7 11.6 ± 1.9 10.8 ± 1.8 0.0001
T
1) aa b c
Platelet, mm
3 276,222 ± 103,955 259,255 ± 92,563 250,831 ± 96,831 235,755 ± 87,964 0.002
T
1) aa , b a , b b
Protein, g/dL 6.7 ± 3.3 6.6 ± 0.9 6.7 ± 3.8 6.3 ± 0.8 0.447
Albumin, g/dL 3.8 ± 0.7 3.8 ± 0.6 3.6 ± 0.7 3.5 ± 0.6 0.0001
T
1) aa a , b b
Total cholesterol, mg/
dL
204 ± 93 208 ± 71 207 ± 87 205 ± 72 0.215
LDL Cholesterol, mg/dL 126 ± 55 113 ± 44 109 ± 34 112 ± 40 0.103
HDL cholesterol, mg/dL 46 ± 16 45 ± 16 42 ± 14 40 ± 12 0.001
T
1) aa , b b , c c
Triglycerides, mg/dL 170 ± 360 151 ± 127 155 ± 95 180 ± 192 0.657
AST, IU/L 29 ± 27 29 ± 20 27 ± 16 29 ± 38 0.108
ALT, IU/L 28 ± 25 28 ± 23 24 ± 20 26 ± 47 0.197
Fasting blood glucose,
mg/dL
153 ± 81 142 ± 74 127 ± 62 127 ± 69 0.0001
T
1) aa , b b b
BUN, mg/dL 12.5 ± 4.5 16.1 ± 5.6 24.3 ± 9.4 38.1 ± 15.5 0.0001
T
1) aa b c
Creatinine, mg/dL 0.71 ± 0.13 0.96 ± 0.16 1.51 ± 0.33 2.86 ± 0.69 0.0001
T
1) ab c d
Total Bilirubin, mg/dL 0.77 ± 0.22 0.76 ± 0.21 0.72 ± 0.22 0.67 ± 0.21 0.0001
T
1) a, b a, b b, c c
Direct Bilirubin, mg/dL 0.31 ± 0.09 0.30 ± 0.09 0.30 ± 0.10 0.28 ± 0.09 0.222
1) The same letters indicate non-significant difference between groups based on Turey’s multiple comparison test
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pared with those of patients with normal proteinuria.
When participants were stratified into categories based
on fasting blood glucose (Table 4), diabetic patients
were hypoalbuminuric compared with non-diabetic
patients. No significant differences were found with
regard to serum total bilirubin concentration between
participants with normal and abnormal fasting blood
glucose levels.
Discussion
To our knowledge, this is the first hospital-based study
specifically aimed at examining the associations among
serum total bilirubin concentration, 24-hour urine pro-
tein and kidney function in Korean adults.
We retrospectively reviewed the medical records of
1363 adults aged 18 years or older who were seen at
Kosin University Gospel Hospital (Busan, Republic of
Korea) in the five-year period from January 2005 to
December 2009. This study demonstrated that serum
total bilirubin concentration was negatively correlated
with 24-hour urine protein and was positively correlated
with eGFR in Korean non-diabetic and diabetic adults.
Our findings are in contrast to the results of Targher
et al. [11] in their observational large hospital-based
sample of 2678 adult outpatients (mean age: 55 ± 18
Figure 1 Correlation between serum total bilirubin
concentration and eGFR in whole subjects (r = 0.128, p =
0.0001).
Figure 2 Correlation between serum total bilirubin
concentration and eGFR in DM subjects (r = 0.202, p = 0.0001).
Figure 3 Correlation between serum total bilirubin
concentration and 24 hour urine protein in whole subjects (r =
-0.228, p = 0.0001).
Figure 4 Correlation between serum total bilirubin
concentration and 24 hour urine protein in DM subjects (r =
-0.227, p = 0.0001).
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study, they found that serum total bilirubin was inver-
sely associated with eGFR in both non-diabetic (r =
-0.17; p < 0.0001) and diabetic patients (r = -0.14; p <
0.05). However, no information was available on albumi-
nuria, comorbidites, alcohol consumption or other
important potential confounders [11]. In this study, we
could not analyzed the effects of alcohol and smoking
on proteinuria, because we were unable to locate data
on alcohol drinking and smoking.
The significant associations between total serum bilir-
ubin and eGFR or albuminuria observed in diabetic
individuals of our cohort were the same as those from
Fukui et al. [10]. That previous study found that total
serum bilirubin was positively associated with eGFR and
negatively associated with albuminuria in a hospital-
based sample of 633 Japanese type 2 diabetic patients
(mean age: 64.4 ± 11.5 years; 52% male). However, in
that study, no adjustment was made for important con-
founders, such as eGFR. In our study, a positive correla-
tion was found between total serum bilirubin
concentration and eGFR in all subjects as well as in dia-
betic patients.
Based on in vitro as well as animal studies, bilirubin is
generally recognized as an important antioxidant sub-
stance. Kumar et al. demonstrated that serum bilirubin
concentration is inversely correlated with a marker of
oxidative stress and is positively correlated with antioxi-
dative enzyme activities such as those of superoxide dis-
mutase, catalase, and glutathione peroxidase [14]. These
results are also supported by clinical studies focused on
the protective effects of serum bilirubin concentration
on atherosclerosis [15-17]. In this study, serum bilirubin
Table 3 Age-gender standardized baseline demographics
and laboratory results according to 24 urine protein
excretion in the entire cohort (n = 1,363)
24 hour urine protein
(mg/day)
<150 ≥ 150 P value
Characteristics n = 810 n = 553
Age, years 55.9 ± 13.9 55.9 ± 14.9 0.642
Sex,% 0.0001
Males 44.7 55.5
Females 55.3 44.5
Diabetes,% 47.4 41.2 0.027
Hypertension,% 8.7 21.6 0.0001
eGFR,%, mL/min/1.73 m
2 0.0001
≥90 35.8 23.1
60-89 44.4 31.1
30-59 16.6 31.5
15-29 3.2 14.3
Measurements
WBC, mm
3 7,296 ± 2,940 8,044 ± 3,216 0.0001
Hb, g/dL 12.5 ± 1.7 11.8 ± 1.9 0.0001
Platelet, mm
3 257,821 ± 93,576 263,793 ± 103,896 0.315
Protein, g/dL 6.8 ± 1.6 6.5 ± 3.7 0.097
Albumin, g/dL 4.0 ± 0.4 3.5 ± 0.7 0.0001
Total cholesterol,
mg/dL
194 ± 49 219 ±103 0.0001
LDL Cholesterol,
mg/dL
115 ± 37 115 ± 49 0.952
HDL cholesterol,
mg/dL
45 ± 15 43 ± 16 0.023
Triglycerides,
mg/dL
148 ± 151 174 ± 272 0.037
AST, IU/L 27 ± 20 29 ± 25 0.139
ALT, IU/L 27 ± 21 27 ± 28 0.898
BUN, mg/dL 16.3 ± 7.9 21.7 ± 12.4 0.0001
Creatinine, mg/dL 0.99 ± 0.41 1.39 ± 0.79 0.0001
Total Bilirubin,
mg/dL
0.78 ± 0.20 0.71 ± 0.22 0.0001
Direct Bilirubin,
mg/dL
0.30 ± 0.09 0.29 ± 0.09 0.003
Table 4 Age-gender standardized baseline demographics
and laboratory results according to fasting blood glucose
(n = 1,363)
Fasting blood glucose,
mg/dL
<126 ≥ 126 P
value
Characteristics
Age, years 53.9 ± 14.6 57.7 ± 13.1 0.0001
Sex,% 0.414
Males 48.1 50.3
Females 51.9 49.7
eGFR,%, mL/min/1.73 m
2 0.0001
≥90 27.5 34.1
60-89 36.3 41.9
30-59 26.6 18.2
15-29 9.6 5.8
Measurements
24 hour urine protein,
mg/day
913 ± 2,350 676 ± 1,870 0.038
WBC, mm
3 7,368 ± 2,942 7,965 ± 3,239 0.001
Hb, g/dL 12.0 ± 1.8 12.3 ± 1.8 0.003
Platelet, mm
3 258,479 ±
97,902
263,037 ±
98,560
0.438
Protein, g/dL 6.7 ± 3.2 6.6 ± 1.9 0.639
Albumin, g/dL 3.7 ±0.7 3.8 ± 0.5 0.046
Total cholesterol, mg/dL 207 ± 78 201 ± 75 0.211
LDL Cholesterol, mg/dL 114 ± 47 115 ± 38 0.877
HDL cholesterol, mg/dL 46 ± 16 42 ± 14 0.0001
Triglycerides, mg/dL 140 ± 97 179 ± 286 0.002
AST, IU/L 28 ± 20 28 ± 25 0.861
ALT, IU/L 24 ± 19 30 ± 29 0.0001
BUN, mg/dL 19.0 ± 11.0 18.1 ± 9.6 0.16
Creatinine, mg/dL 1.24 ± 0.69 1.06 ± 0.55 0.0001
Total Bilirubin, mg/dL 0.75 ± 0.21 0.76 ± 0.21 0.499
Direct Bilirubin, mg/dL 0.30 ± 0.09 0.30 ± 0.08 0.705
eGFR, mL/min/1.73 m
2 71 ± 31 80 ± 30 0.0001
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positively correlated with renal function, and total cho-
lesterol in the normal proteinuria group level was lower
than that in the abnormal proteinuria group. However,
we were unable to assess the antioxidant effect of serum
bilirubin, because tests for an oxidative stress marker
and antioxidant enzyme were not carried out.
In addition to being an antioxidant, bilirubin also has
anticomplement properties that protect against inflam-
mation [18]. Furthermore, bilirubin has been suggested
to have cytoprotective properties through its influence
on protein kinase C [19]. Through these mechanisms,
bilirubin could protect diabetic patients from the devel-
opment and progression of diabetic nephropathy
[20-23]. However, in this study, the 24-hour proteinuria
level in the diabetic group was lower than that in the
non-diabetic group because CKD patients were included
in the non-diabetic group.
In results of this study, we might think serum biliru-
bin concentration may be utilized as a provisional new
risk factor of diabetic nephropathy that can be measured
easily in the clinical laboratory and applied in medical
practice.
It could be hypothesized that the bilirubin-kidney dys-
function relationship primarily reflects the association of
serum bilirubin concentration with non-alcoholic fatty
liver disease (NAFLD). NAFLD represents the most
common cause of mild to moderate increases in serum
bilirubin and other liver enzymes in Western countries
[24]. Recent studies have found that NAFLD is indepen-
dently associated with an increased incidence of CKD in
both non-diabetic and diabetic populations [25,26].
Limitations of our study include its cross-sectional
design, which allows us to identify only associations
and should not yield any conclusions about causation.
In addition, results of this study may not be applicable
to the general population or to patients with type 2
diabetes in a primary care clinic because the data were
collected from patients in an outpatient clinic of a uni-
versity hospital. This study’s results are not definitive
because a Pearson’s correlation coefficient of less than
± 0.25 is generally considered to be a weak correlation.
We think prompt further research into this interesting
correlation will be needed. Second, we were unable to
explain the reason why both the non-diabetic and dia-
betic group had the same results. Third, liver ultraso-
nography for diagnosing NAFLD was not performed.
F i n a l l y ,w eu s e de G F Ri n s t e a do fad i r e c t l ym e a s u r e d
GFR to assess renal function. It is known that current
eGFR experiences greater inaccuracy in populations
with no known CKD than in those with CKD. None-
theless, the current eGFR technique facilitates the
detection, evaluation, and management of renal
disease.
To our knowledge, this is the first study to investigate
the relationship between serum bilirubin concentration
and 24-hour urine protein excretion in non-diabetic sub-
jects and in patients with type 2 diabetes. Although we are
unable to determine whether hypobilirubinemia has a cau-
sative effect, these findings suggest that hypobilirubinemia
combined with diabetes might be associated with
advanced diabetic nephropathy. Large prospective trials
are needed to better assess the effects of bilirubin on dia-
betic nephropathy in patients with type 2 diabetes.
Conclusions
our findings suggest that increasing serum total bilirubin
concentration is associated with increasing eGFR and
decreasing albuminuria in Korean non-diabetic and dia-
betic adults.
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